Home > Healthcare > Pharmaceuticals > Myoglobin Market

Myoglobin Market Trends

Report ID: GMI9188
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Myoglobin Market Trends

The rising prevalence of cardiovascular diseases is a significant driver for the market, contributing to increased demand for diagnostic tests and healthcare services related to cardiac health.
Cardiovascular diseases, including coronary artery disease, myocardial infarction (heart attack), and heart failure, are leading causes of morbidity and mortality worldwide. For instance, as per a study conducted by the American College of Cardiology, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022 reflecting a significant increase in the disease burden.
As the prevalence of these conditions rises, there is a greater need for diagnostic tests, including myoglobin assays, to aid in the early detection, risk assessment, and management of cardiac-related disorders.
Additionally, increasing healthcare expenditure and technological advancements further increases the adoption of myoglobin-based diagnostic tests. This trend prompts healthcare providers to invest in advanced diagnostic technologies, enhancing patient outcomes, thereby fueling market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global myoglobin market was valued at USD 98.5 million in 2023 and will grow at 4.3% CAGR between 2024-2032, driven by the increasing demand for diagnostic testing.

Human myoglobin from product segment held a market share of 70.3% in 2023 and will grow rapidly till 2032, driven by its effectiveness in the early diagnosis of heart conditions.

North America myoglobin market size was valued at USD 42 million in 2023 and will grow at 4.1% CAGR during the forecast timeframe, driven by advanced healthcare infrastructure and sophisticated diagnostic capabilities.

Abnova Corporation, biomérieux SA, Beckman Coulter, Inc. (Danaher Corp), Boditech Med Inc., Calzyme, Merck KGaA , OriGene Technologies, Inc. among others.